Precision Diagnostics market expected to reach USD 254.48 billion by 2033 with CAGR of 13%.

From GlobeNewswire: 2024-07-05 04:00:00

The Global Precision Diagnostics Market is set to grow from USD 74.98 Billion in 2023 to USD 254.48 Billion by 2033, with a CAGR of 13%. Precision medicine diagnostics tailor treatments for individual patients, mainly used for cancer and diabetes. Genetic testing, molecular profiling, imaging are crucial for precise diagnostics.

Among genetic, esoteric tests, genetic tests lead the precision diagnostics market due to early disease diagnosis potential. In the application segment, oncology is expected to have the fastest growth, transforming oncology diagnosis and therapy. Clinical laboratories are predicted to show the highest growth in the end user segment, benefiting from modern equipment.

North America is projected to dominate the global precision diagnostics market, valued at USD 28.34 billion in 2023. Asia Pacific is anticipated to have the fastest growth due to increasing acceptance of precision diagnostics and government initiatives. Key players in the market include Abbott Laboratories, Roche, Siemens Healthineers, and more, driving innovation and strategic alliances.

Recent developments include HALO Precision Diagnostics partnering with Agamon Health to improve patient experience. Market segments cover type (genetic tests, esoteric tests, others), application (oncology, cardiovascular), end user (hospitals, clinics), and regional analysis. Spherical Insights provides actionable market research and consulting for various sectors.



Read more at GlobeNewswire: Global Precision Diagnostics Market Size To Worth USD